Clinical indications for therapeutic drug monitoring of antifungal agents. In the way for optimizing the treatment of fungal infection

被引:0
|
作者
Cendejas-Bueno, Emilio [1 ]
Cuenca-Estrella, Manuel [1 ]
Gomez-Lopez, Alicia [1 ]
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Microbiol Serv, Majadahonda 28220, Madrid, Spain
关键词
serum concentrations; Voriconazole; Posaconazole; Itraconazole; PERFORMANCE-LIQUID-CHROMATOGRAPHY; CELL TRANSPLANT RECIPIENTS; SOLID-PHASE EXTRACTION; LC-MS/MS METHOD; ITRACONAZOLE SERUM CONCENTRATIONS; HYDROXYPROPYL-BETA-CYCLODEXTRIN; REFERENCE LABORATORY EXPERIENCE; COLUMN-SWITCHING TECHNIQUE; TANDEM MASS-SPECTROMETRY; HIGH-DOSE FLUCONAZOLE;
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Therapeutic drug monitoring as a tool in the management of infectious diseases has been introduced in therapy with anti-infective agents for years. Nowadays, it has taken importance in the management of fungal diseases due to the appearance of new antifungal drugs such as new-generation azoles. These azoles have pharmacokinetic characteristics that hinder a proper use to ensure efficacy and minimize toxicity. Monitoring of serum concentrations may help in the better use of these anti-infective agents, as well as in a better management of drug interactions, infectious disease and adverse effects. It has resulted in saving costs of treatment and in avoiding inadequate dosages. This review will attempt to clarify the role of the antifungal agents Therapeutic Drug Monitoring, highlighting the role of azole compounds.
引用
收藏
页码:1 / 16
页数:16
相关论文
共 50 条
  • [21] Quinalizarin as a potential antifungal drug for the treatment of Candida albicans fungal infection in cancer patients
    Janeczko, Monika
    Kochanowicz, Elzbieta
    Gorka, Kamila
    Skrzypek, Tomasz
    MICROBIOLOGY SPECTRUM, 2024, 12 (03):
  • [22] Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice
    Yoon, S. J.
    Lee, K. H.
    Oh, J. W.
    Woo, H. I.
    Lee, S. Y.
    CLINICA CHIMICA ACTA, 2019, 493 : S73 - S74
  • [23] Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice
    Yoon, Sun Joo
    Lee, Kyunghoon
    Oh, Jongwon
    Woo, Hye In
    Lee, Soo-Youn
    CLINICAL BIOCHEMISTRY, 2019, 70 : 14 - 17
  • [24] Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology
    Ashbee, H. Ruth
    Barnes, Rosemary A.
    Johnson, Elizabeth M.
    Richardson, Malcolm D.
    Gorton, Rebecca
    Hope, William W.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (05) : 1162 - 1176
  • [25] The Clinical Significance of Voriconazole Therapeutic Drug Monitoring in Children With Invasive Fungal Infections
    Kang, Hyun Mi
    Lee, Hoan Jong
    Cho, Eun Young
    Yu, Kyung-Sang
    Lee, Hyunju
    Lee, Ji Won
    Kang, Hyoung Jin
    Park, Kyung Duk
    Shin, Hee Young
    Choi, Eun Hwa
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2015, 32 (08) : 557 - 567
  • [26] A current appraisal of drug interactions of significance in clinical practice: Focus on antifungal therapeutic agents used in the treatment of superficial mycoses
    Del Rosso, JQ
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (03) : P172 - P172
  • [27] Therapeutic Drug Monitoring in Buprenorphine/Naloxone Treatment for Opioid Use Disorder: Clinical Feasibility and Optimizing Assay Precision
    Elarabi, Hesham Farouk
    Hasan, Nael
    Marsden, John
    Radwan, Doaa
    Adem, Abdu
    Almamari, Samya
    Elrasheed, Abuelgasim
    PHARMACOPSYCHIATRY, 2020, 53 (03) : 115 - 121
  • [28] On the benefits of therapeutic drug monitoring for patients undergoing treatment with antipsychotic agents
    Mercolini, Laura
    Protti, Michele
    Mandrioli, Roberto
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (02) : 121 - 122
  • [29] Update on Therapeutic Drug Monitoring of Antifungals for the Prophylaxis and Treatment of Invasive Fungal Infections
    Schwartz I.S.
    Wiederhold N.P.
    Current Fungal Infection Reports, 2017, 11 (3) : 75 - 83
  • [30] Therapeutic drug monitoring and safety evaluation of voriconazole in the treatment of pulmonary fungal diseases
    Shen, Kunlu
    Gu, Yu
    Wang, Yu
    Lu, Yajie
    Ni, Yueyan
    Zhong, Huanhiuan
    Shi, Yi
    Su, Xin
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2022, 13